Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Feng Chi BiotechROCO:6744 82 5-Year Yield-on-Cost % is 5.77 as of Aug. 10, 2026, which is 7% above its 10-year median of 5.41. GuruFocus rates ROCO:6744 with a GF Score™ of 82/100 and a GF Value™ of NT$20.78 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 150 Biotechnology companies, Feng Chi Biotech ranks better than 83.33% on this metric.
Feng Chi Biotech's yield on cost for the quarter that ended in Dec. 2025 was 5.77.
The historical rank and industry rank for Feng Chi Biotech's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:6744'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.86 Med: 5.41 Max: 7.03
Current: 5.77
During the past 10 years, Feng Chi Biotech's highest Yield on Cost was 7.03. The lowest was 2.86. And the median was 5.41.
ROCO:6744's 5-Year Yield-on-Cost % is ranked better than 83.33% of 150
companies
in the Biotechnology industry
Industry Median: 1.6
vs ROCO:6744: 5.77
Feng Chi Biotech (ROCO:6744) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Feng Chi Biotech 5-Year Yield-on-Cost % Related Terms
ROCO:6744 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Feng Chi Biotech's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Feng Chi Biotech 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Feng Chi Biotech's 5-Year Yield-on-Cost % falls into.
Feng Chi Biotech 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Feng Chi Biotech (ROCO:6744) has a 5-Year Yield-on-Cost % of 5.77 as of Aug. 10, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Feng Chi Biotech and its competitors. This is near median its historical median of 5.41. Over the past decade, Feng Chi Biotech's 5-Year Yield-on-Cost % has ranged from 2.86 to 7.03. According to the industry distribution chart, Feng Chi Biotech ranks #25 out of 150 companies in the Biotechnology industry, placing it in the top 16.7%.
Is Feng Chi Biotech's 5-Year Yield-on-Cost % too high?
Feng Chi Biotech's current 5-Year Yield-on-Cost % of 5.77 is near median its 10-year median of 5.41. Over the past 10 years, this metric has ranged from a low of 2.86 to a high of 7.03. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.60. Feng Chi Biotech's value of 5.77 is 260.6% above this industry median. Based on the distribution chart, Feng Chi Biotech ranks #25 out of 150 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Feng Chi Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Feng Chi Biotech's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Feng Chi Biotech ranks #25 out of 150 companies for 5-Year Yield-on-Cost %. This places Feng Chi Biotech in the top 17% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 1.60. Feng Chi Biotech's value of 5.77 is 260.6% above this benchmark. Historically, Feng Chi Biotech's own 5-Year Yield-on-Cost % has ranged from 2.86 to 7.03 over the past decade. While the company's 10-year median is 5.41 vs. the industry median of 1.60, Feng Chi Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.60, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Feng Chi Biotech's current 5-Year Yield-on-Cost % of 5.77 is 260.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Feng Chi Biotech and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Feng Chi Biotech's current 5-Year Yield-on-Cost % is 5.77, which is near median its own 10-year median of 5.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feng Chi Biotech stock overvalued right now?
Based on GuruFocus' analysis, Feng Chi Biotech (ROCO:6744) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$20.78, compared to a current price of NT$14.70 — trading 29.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.77, which is near median its 10-year median of 5.41 and 260.6% above the Biotechnology industry median of 1.60. Feng Chi Biotech's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Feng Chi Biotech (ROCO:6744), the current 5-Year Yield-on-Cost % is 5.77 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Feng Chi Biotech (ROCO:6744) Overvalued in 2026?
Based on GuruFocus' analysis, Feng Chi Biotech stock appears to be undervalued.
The current stock price of NT$14.70 is trading 29.3% below its estimated GF Value™ of NT$20.78.
GuruFocus considers Feng Chi Biotech to be Modestly Undervalued.
Key valuation signals for ROCO:6744:
5-Year Yield-on-Cost %: 5.77 (near median its 10-year median of 5.41)
GF Value™: NT$20.78 vs. price of NT$14.70 (29.3% below fair value)
Industry Position: 260.6% above the Biotechnology median (#25 of 150)
No single metric tells the full story. See the ROCO:6744 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
82GF Score
Get the complete analysis for ROCO:6744
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6744 has been successfully added to your 
